Scotia Capital »

Eyepoint Pharmaceuticals shares owned by Scotia Capital

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Scotia Capital from 13F filings

Historical chart of Scotia Capital investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Scotia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Scotia Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $538k 42k 12.89
2025-12-31 $577k 32k 18.27
2025-09-30 $450k 32k 14.24
2025-06-30 $297k 32k 9.41
2025-03-31 $171k 32k 5.42
2024-12-31 $93k 12k 7.45
2024-09-30 $99k 12k 7.99
2023-12-31 $207k 9.0k 23.11
2023-09-30 $727k 91k 7.99
2023-06-30 $323k 37k 8.70